China Pharma Holdings (CPHI) Other financing activities (2011 - 2012)
China Pharma Holdings (CPHI) posted Other financing activities of $1.3 million for Q3 2012, down 73.96% on a QoQ basis from $5.0 million in Q3 2011, and down 73.96% year-over-year from $5.0 million in Q4 2011.
China Pharma Holdings (CPHI) Other financing activities (2011 - 2012) Analysis & Trends
China Pharma Holdings' Other financing activities history runs 2 years deep, the most recent figure standing at $1.3 million for Q3 2012.
- Quarterly Other financing activities fell 73.96% year-over-year to $1.3 million in Q3 2012, while the trailing twelve-month figure through Sep 2012 was $6.3 million (changed N/A YoY) and the FY2010 annual result came in at $2.6 million, changed N/A from the prior year.
- Other financing activities was $1.3 million for Q3 2012 at China Pharma Holdings, down from $5.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $5.0 million in Q3 2011 and bottomed at $1.3 million in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 1.30 Mn |
| Sep 30, 2012 | 1.30 Mn |
| Sep 30, 2011 | 4.97 Mn |
| Sep 30, 2011 | 4.97 Mn |